Better Therapeutic Trials in Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Better Therapeutic Trials in Ovarian Cancer

Published:2014-03-13 Issue:4 Volume:106 Page:dju029-dju029
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Bookman M. A.,Gilks C. B.,Kohn E. C.,Kaplan K. O.,Huntsman D.,Aghajanian C.,Birrer M. J.,Ledermann J. A.,Oza A. M.,Swenerton K. D.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/106/4/dju029/8097072/dju029.pdf

Reference38 articles.

1. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

2. Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma

3. Grading Ovarian Serous Carcinoma Using a Two-Tier System

4. Transitional Cell Carcinoma of the Ovary is Related to High-grade Serous Carcinoma and is Distinct From Malignant Brenner Tumor

5. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of mesoporous silica coated gold nanorods for biological imaging and cancer therapy;ChemMedChem;2023-11-22

2. Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinoma;International Journal of Clinical Oncology;2023-10-07

3. Scutellaria baicalensis Georgi and Their Natural Flavonoid Compounds in the Treatment of Ovarian Cancer: A Review;Molecules;2023-06-29

4. Right middle cerebral artery stroke secondary to ovarian clear cell carcinoma in a 35-year-old: A case report;Case Reports in Women's Health;2023-03

5. A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway;Journal of Nanobiotechnology;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3